Venus Medtech International

medical devices

About

Venus Medtech International, based in Hangzhou, China, is a leading medical device company focused on transcatheter structural heart valve therapies. Founded in 2009, the company has established a strong presence in nearly 70 global markets, including Europe, Asia-Pacific, and Latin America. With around 691 employees, Venus Medtech is led by CEO Hou-Sen Lim and holds over 800 patents worldwide. The company offers a diverse range of products, including the VenusA-Valve series for aortic valve replacement, the VenusP-Valve for pulmonary valve treatment, and the Cardiovalve system for mitral regurgitation. Additionally, Venus Medtech develops other medical devices, such as a radiofrequency ablation system for hypertrophic cardiomyopathy and a renal artery denervation system for hypertension. The company is committed to innovation and actively conducts clinical trials to enhance its product offerings and expand treatment options for structural heart diseases.

Technologies

DNS.com OpenSSL Bootstrap Framework Mobile Friendly Baidu Ads Google Tag Manager Apache Remote

Keywords

medical equipment manufacturing healthcare equipment & supplies catheter-based procedures venus-powerx medical device development heart valve replacement venusa-plus venusp-valve clinical trials tavr minimally invasive cardiovascular devices cardiovascular innovation regulatory submissions lockwire technology transcatheter heart valve valve technology delivery systems medical equipment and supplies manufacturing distribution venus vitae cardiovascular devices b2b venus-endura medical devices biocompatible materials manufacturing dragonfly venusa-valve fda approval leaflex

Location

137 Kraijenhoffstraat, Amsterdam, North Holland, Netherlands, 1018 RG

Related Companies

Companies in the same industry